Dataset Information

Discovery of Spiro[cyclohexane-dihydropyrano[3,4-b]indole]-amines as Potent NOP and Opioid Receptor Agonists.

ABSTRACT: We report the discovery of spiro[cyclohexane-pyrano[3,4-b]indole]-amines, as functional nociceptin/orphanin FQ peptide (NOP) and opioid receptor agonists with strong efficacy in preclinical models of acute and neuropathic pain. Utilizing 4-(dimethylamino)-4-phenylcyclo-hexanone 1 and tryptophol in an oxa-Pictet-Spengler reaction led to the formation of spiroether 2, representing a novel NOP and opioid peptide receptor agonistic chemotype. This finding initially stems from the systematic derivatization of 1, which resulted in alcohols 3-5, ethers 6 and 7, amines 8-10, 22-24, and 26-28, amides 11 and 25, and urea 12, many with low nanomolar binding affinities at the NOP and mu opioid peptide (MOP) receptors.

SUBMITTER: Schunk S

PROVIDER: S-EPMC4137372 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Discovery of Spiro[cyclohexane-dihydropyrano[3,4-b]indole]-amines as Potent NOP and Opioid Receptor Agonists.

Schunk Stefan S Linz Klaus K Frormann Sven S Hinze Claudia C Oberbörsch Stefan S Sundermann Bernd B Zemolka Saskia S Englberger Werner W Germann Tieno T Christoph Thomas T Kögel Babette-Y BY Schröder Wolfgang W Harlfinger Stephanie S Saunders Derek D Kless Achim A Schick Hans H Sonnenschein Helmut H

ACS medicinal chemistry letters 20140624 8

We report the discovery of spiro[cyclohexane-pyrano[3,4-b]indole]-amines, as functional nociceptin/orphanin FQ peptide (NOP) and opioid receptor agonists with strong efficacy in preclinical models of acute and neuropathic pain. Utilizing 4-(dimethylamino)-4-phenylcyclo-hexanone 1 and tryptophol in an oxa-Pictet-Spengler reaction led to the formation of spiroether 2, representing a novel NOP and opioid peptide receptor agonistic chemotype. This finding initially stems from the systematic derivati ...[more]

PMID: 25147602

Dataset Information

Discovery of Spiro[cyclohexane-dihydropyrano[3,4-b]indole]-amines as Potent NOP and Opioid Receptor Agonists.

Publications

Discovery of Spiro[cyclohexane-dihydropyrano[3,4-b]indole]-amines as Potent NOP and Opioid Receptor Agonists.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Similar Datasets

Novel Mixed NOP/Opioid Receptor Peptide Agonists.
| S-EPMC8279409 | biostudies-literature

Discovery of a Potent Analgesic NOP and Opioid Receptor Agonist: Cebranopadol.
| S-EPMC4137374 | biostudies-literature

Development of potent ? and ? opioid agonists with high lipophilicity.
| S-EPMC3136578 | biostudies-literature

Discovery of Kynurenines Containing Oligopeptides as Potent Opioid Receptor Agonists.
| S-EPMC7072329 | biostudies-literature

Discovery of Tertiary Amine and Indole Derivatives as Potent ROR?t Inverse Agonists.
| S-EPMC4027777 | biostudies-literature

Discovery of nonpeptide 3,4-dihydroquinazoline-4-carboxamides as potent and selective sst2 agonists.
| S-EPMC7508466 | biostudies-literature

Design, synthesis, and evaluation of potent novel peroxisome proliferator-activated receptor γ indole partial agonists.
| S-EPMC7243741 | biostudies-literature

Synthesis of functionalized spiro[indoline-3,4'-pyridines] and spiro[indoline-3,4'-pyridinones] via one-pot four-component reactions.
| S-EPMC3678513 | biostudies-literature

Opioid agonists as potential AML therapy
2023-03-20 | GSE147511 | GEO

Activities of mixed NOP and mu-opioid receptor ligands.
| S-EPMC2241792 | biostudies-other